Agilent Technologies Inc
A
$146.36 2.09%
Exchange: NYSE | Sector: Healthcare | Industry: Medical Diagnostics Research
Q3 2024
Published: Aug 30, 2024

Earnings Highlights

  • Revenue of $1.58B down 5.6% year-over-year
  • EPS of $0.97 increased by 155.3% from previous year
  • Gross margin of 54.2%
  • Net income of 282.00M
  • ""We're investing in our digital ecosystem to further enhance our differentiated customer experience."" - Padraig McDonnell

Agilent Technologies Inc (A) Q3 2024 Financial Results Report: Navigating Market Headwinds with Strategic Growth

Executive Summary

Agilent Technologies Inc reported third-quarter 2024 revenues of $1.578 billion, reflecting a decline of 4.4% on a core basis, yet a 300 basis point improvement from Q2 2024. The operating margin improved to 27.4% as a result of enhanced cost efficiency measures aimed at achieving $100 million in annualized savings. Adjusted earnings per share (EPS) came in at $1.32, exceeding guidance by $0.04. In a challenging operating environment, Agilent has witnessed solid growth in services and consumables, with management expressing optimism regarding the acceleration of demand in upcoming quarters. Key growth vectors include the biopharma sector and sustainable solutions, underpinned by recent acquisitions which strengthen Agilent’s digital ecosystem and product offerings.

Key Performance Indicators

Revenue

1.58B
QoQ: 0.32% | YoY:-5.62%

Gross Profit

855.00M
54.18% margin
QoQ: -0.12% | YoY:29.94%

Operating Income

333.00M
QoQ: -8.26% | YoY:150.38%

Net Income

282.00M
QoQ: -8.44% | YoY:154.05%

EPS

0.97
QoQ: -7.62% | YoY:155.26%

Revenue Trend

Margin Analysis

Key Insights

1. **Revenue:** $1.578 billion (-5.6% YoY) 2. **Gross Profit:** $855 million (Gross Margin: 54.2%) 3. **Operating Income:** $333 million (Operating Margin: 27.4%) 4. **Net Income:** $282 million 5. **EPS:** $1.32, up 4.1% from guidance. 6. **Operating Cash Flow:** $452 million, benefiting from strong resource management. 7. **Balance Sheet Health:** Cash and equivalents stood at $1.779 billion, with total debt of $2.932 billion reflecting a net leverage ratio of 0.60. 8. **Return on Equity (ROE...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 1,668.00 0.75 +6.0% View
Q1 2025 1,681.00 1.11 +1.4% View
Q4 2024 1,701.00 1.21 +0.8% View
Q3 2024 1,578.00 0.97 -5.6% View
Q2 2024 1,573.00 1.05 -8.4% View